{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T23:30:15Z","timestamp":1680823815178},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1986,6]]},"DOI":"10.1007\/bf00306739","type":"journal-article","created":{"date-parts":[[2004,10,10]],"date-time":"2004-10-10T03:47:58Z","timestamp":1097380078000},"page":"121-126","source":"Crossref","is-referenced-by-count":5,"title":["Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography"],"prefix":"10.1007","volume":"17","author":[{"given":"G.","family":"Akel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Benard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Canal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Soula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"67","volume":"14","author":"G Akel","year":"1983","unstructured":"Akel G, Canal P, Mockey E, Vandevoorde E, Laurent F, Soula G (1983) Comparison of the fate of misonidazole (Ro 07-0582) and its metabolite desmethylmisonidazole (Ro 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor-bearing rats. J Pharmacol (Paris) 14:67","journal-title":"J Pharmacol (Paris)"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/bjc.1979.93","volume":"39","author":"DV Ash","year":"1979","unstructured":"Ash DV, Smith MR, Budgen RD (1979) Distribution of misonidazole in human tumours and normal tissues. Br J Cancer 39:503","journal-title":"Br J Cancer"},{"key":"CR3","first-page":"457","volume":"67","author":"P Benard","year":"1983","unstructured":"Benard P, Desplanches G, Macquet JP, Simon J (1983) Whole-body autoradiographic study of the distribution of 195 mPt in healthy and tumor-bearing mice treated with labelled cisplatin. Cancer Treat Rep 67:457","journal-title":"Cancer Treat Rep"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/bjc.1979.55","volume":"39","author":"JM Brown","year":"1979","unstructured":"Brown JM, Yu NY, Workman P (1979) Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours. Br J Cancer 39:310","journal-title":"Br J Cancer"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.1981.79","volume":"43","author":"JD Chapman","year":"1981","unstructured":"Chapman JD, Franko AJ, Sharplin J (1981) A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer 43:546","journal-title":"Br J Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2307\/3575510","volume":"86","author":"JB Chin","year":"1981","unstructured":"Chin JB, Rauth AM (1981) The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice. Radiat Res 86:341","journal-title":"Radiat Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/bjc.1977.90","volume":"35","author":"S Dische","year":"1977","unstructured":"Dische S, Saunders MI, Lee ME, Adams GE, Flockhart IR (1977) Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer 35:567","journal-title":"Br J Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0041-008X(80)90420-2","volume":"53","author":"S Durand","year":"1980","unstructured":"Durand S, Benard P (1980) Whole-body autoradiographic study of the distribution of radioactivity in rats given L-[1,2-ethyl-14C] ethionine. Toxicol Appl Pharmacol 53:204","journal-title":"Toxicol Appl Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00498257809060388","volume":"8","author":"IR Flockhart","year":"1978","unstructured":"Flockhart IR, Large P, Troup D, Malcolm SL, Marten TR (1978) Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole. Xenobiotica 8:97","journal-title":"Xenobiotica"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/bjc.1982.110","volume":"45","author":"AJ Franko","year":"1982","unstructured":"Franko AJ, Chapman JD (1982) Binding of 14C-misonidazole to hypoxic cells in V79 spheroids. Br J Cancer 45:694","journal-title":"Br J Cancer"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-9260(76)80137-7","volume":"27","author":"AJ Gray","year":"1976","unstructured":"Gray AJ, Dische S, Adams GE, Flockhart IR, Foster JL (1976) Clinical testing of the radiosensitizer Ro 07-0582: I. Dose, tolerance, serum and tumour concentrations. Clin Radiol 27:151","journal-title":"Clin Radiol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","volume":"26","author":"LH Gray","year":"1953","unstructured":"Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA (1953) The concentration of oxygen dissolved in tissue at time of irradiation as a factor in radiotherapy. Br J Radiol 26:638","journal-title":"Br J Radiol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/bjc.1981.65","volume":"43","author":"PD Josephy","year":"1981","unstructured":"Josephy PD, Placic B, Skarsgard LD (1981) In vitro metabolism of misonidazole. Br J Cancer 43:443","journal-title":"Br J Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/0006-2952(80)90304-4","volume":"29","author":"RL Koch","year":"1980","unstructured":"Koch RL, Beaulieu BB Jr, Goldman P (1980) Role of the intestinal flora in the metabolism of misonidazole. Biochem Pharmacol 29:3281","journal-title":"Biochem Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bjc.1982.44","volume":"45","author":"AI Langler","year":"1982","unstructured":"Langler AI, Budgen RD, Gibson P (1982) The penetration of misonidazole into mature structural cartilage. Br J Cancer 45:282","journal-title":"Br J Cancer"},{"key":"CR16","first-page":"669","volume":"219","author":"ME McManus","year":"1981","unstructured":"McManus ME, Monks A, Collins JM, White R, Strong J (1981) Non-linear pharmacokinetics of misonidazole and desmethyl-misonidazole in the isolated perfused rat liver. J Pharmacol Exp Ther 219:669","journal-title":"J Pharmacol Exp Ther"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0006-2952(82)90158-7","volume":"31","author":"ME McManus","year":"1982","unstructured":"McManus ME, Lang MA, Stuart K, Strong JM (1982) Activation of misonidazole by liver microsomes and purified NADPH cytochrome C reductase. Biochem Pharmacol 31:547","journal-title":"Biochem Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2307\/3574958","volume":"73","author":"NJ McNally","year":"1978","unstructured":"McNally NJ, Denekamp J, Sheldon P, Flockhart IR, Stewart FA (1978) Radiosensitization by misonidazole: the importance of timing and tumour concentration of sensitizer. Radiat Res 73:568","journal-title":"Radiat Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/bjc.1979.76","volume":"39","author":"JE Pedersen","year":"1979","unstructured":"Pedersen JE, Smith MR, Budgen RD, Peckham MJ (1979) Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro 07-0582) in C57 mice. Br J Cancer 39:429","journal-title":"Br J Cancer"},{"key":"CR20","first-page":"276","volume":"37","author":"TL Phillips","year":"1978","unstructured":"Phillips TL, Wasserman TM, Johnson RJ, Gomer CJ, Lawrence GA, Levine ML, Sadee W, Penta JS, Rubin DJ (1978) The hypoxic cell sensitizer programme in the United States. Br J Cancer 37:276","journal-title":"Br J Cancer"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0014-2964(81)90239-5","volume":"17","author":"K Sakamoto","year":"1981","unstructured":"Sakamoto K, Aritake S (1981) Effects of misonidazole on tumour cell radiation sensitivity and potentially lethal damage repair in vivo and in vitro. Eur J Cancer Clin Oncol 17:825","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR22","first-page":"1343","volume":"66","author":"DD Shoemaker","year":"1982","unstructured":"Shoemaker DD, McManus ME, Hoerauf R, Strong JM (1982) Studies on the O-demethylation of misonidazole by rat liver microsomes. Cancer Treat Rep 66:1343","journal-title":"Cancer Treat Rep"},{"key":"CR23","first-page":"22","volume-title":"Radiation sensitizers","author":"CE Smithen","year":"1980","unstructured":"Smithen CE, Clarke ED, Dale JA, Jacobs RS, Wardman P, Watts ME, Woodcock M (1980) Novel (nitroimidazolyl) alkanolamines as potential radiosensitizers with improved therapeutic properties. In: Brady LW (ed) Radiation sensitizers. Masson New York, 22"},{"key":"CR24","first-page":"3776","volume":"42","author":"FL Sweeney","year":"1982","unstructured":"Sweeney FL, Pot-Deprun J, Poupon MF, Chouroulinkov I (1982) Heterogeneity of growth and metastatic behavior of cloned cell lines derived from a primary rhabdomyosarcoma. Cancer Res 42:3776","journal-title":"Cancer Res"},{"key":"CR25","first-page":"1","volume":"118","author":"S Ullberg","year":"1954","unstructured":"Ullberg S (1954) Studies on the distribution and fate of 35S-labelled benzypenicillin in the body. Acta Radiol [Suppl] 118:1","journal-title":"Acta Radiol [Suppl]"},{"key":"CR26","unstructured":"Ullberg S (1977) The technique of whole-body autoradiographic study. Science Tools, Special issue: 2"},{"key":"CR27","first-page":"271","volume":"37","author":"RC Urtasun","year":"1978","unstructured":"Urtasun RC, Chapman JD, Feldstein ML, Band RP, Rabin HR, Wilson AF, Marynowsky B, Starreveld E, Shnitka T (1978) Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer 37:271","journal-title":"Br J Cancer"},{"key":"CR28","first-page":"2165","volume":"40","author":"AJ Varghese","year":"1980","unstructured":"Varghese AJ, Whitmore GF (1980) Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. Cancer Res 40:2165","journal-title":"Cancer Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/bjc.1979.187","volume":"40","author":"P Workman","year":"1979","unstructured":"Workman P (1979) Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer 40:335","journal-title":"Br J Cancer"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00578559","volume":"5","author":"P Workman","year":"1980","unstructured":"Workman P (1980) Dose-dependance and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice. Cancer Chemother Pharmacol 5:27","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00306739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00306739\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00306739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T16:52:41Z","timestamp":1554742361000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00306739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,6]]}},"alternative-id":["BF00306739"],"URL":"https:\/\/doi.org\/10.1007\/bf00306739","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,6]]}}}